What is HAIRGENESIS®
Q: Is HAIRGENESIS® safe for women?
A: With over twenty-five years of clinical and research data to support safety and efficacy, HAIRGENESIS® has established an excellent safety track record in women as well as men.
Q: What are the side effects of HAIRGENESIS®?
A: No negative side effects have been reported when HAIRGENESIS® is used as directed.
Q: How long does HAIRGENESIS® take to work?
A: Typical results occur within the first 90 days of usage. The first sign of positive benefit is generally a reduction in the rate of hair loss observed. The overall ‘health and vitality’ of the hair may also soon begin to improve. In those who respond positively to treatment, with continued usage, the density and ‘fullness’ of the hair also tends to improve.
Q: How do I know HAIRGENESIS® will work for me?
A: The most frequent form of hair loss is known as androgenetic alopecia, also known as ‘common pattern hair loss’. This disorder affects more than 95% of men and women who notice hair loss. HAIRGENESIS® has been specifically designed and formulated to ameliorate androgenetic alopecia.
Q: What happens if I stop using HAIRGENESIS®? Will my hair stay thick?
A: Because there is no ‘cure’ for pattern hair loss, the benefits associated with HAIRGENESIS® persist only so long as therapy is continued
Q: Will HAIRGENESIS® grow hair in places other than the scalp?
A: No, because hair in other anatomical regions of the body is regulated by genetic and biochemical factors that are distinct from those operative in the scalp.
Q: How does HAIRGENESIS® compare to minoxidil (Rogaine™)?
A: Rogaine™ (2% minoxidil / 5% minoxidil) is a pharmaceutical, topically administered drug with known negative side effects. Further, maximum strength (5%) minoxidil is not indicated as safe for use by women. On the other hand, Maximum Strength HAIRGENESIS®, in a concomitant oral and topical form, is considered safe and effective for use by women as well as men. With more than twenty years of clinical experience, HAIRGENESIS® has also established an exemplary track record for safety.
Q: How does HAIRGENESIS® compare to finasteride (Propecia™)?
A: Propecia™ (1 mg finasteride) is a pharmaceutical oral drug with known negative side effects – these include feminizing birth defects, gynecomastia and impotence. Further, finasteride in any dosage is not indicated as safe for use by women. On the other hand, Maximum Strength HAIRGENESIS®, in concomitant oral and topical form, is considered safe and effective for use by women as well as men. Pointedly, in a recent University of Chicago study, HAIRGENESIS® was tested against Propecia™ (1 mg finasteride). This peer-reviewed and published study showed that HAIRGENESIS® outperformed benchmark drug finasteride by a statistically substantial margin. Here’s a link to that study: https://pubmed.ncbi.nlm.nih.gov/26990224/ With more than twenty-five years of clinical experience, HAIRGENESIS® has also established an exemplary track record for safety.
Q: How does HAIRGENESIS® compare to Nioxin Keranique Shen min etc…
A: There are today numerous products which purport to reduce hair loss and/or restore thinning hair to fuller density. However, aside from the pharmaceutical drugs (e.g. minoxidil & finasteride) only HAIRGENESIS® can back its claims with IRB-monitored, placebo-controlled, double-blind, university based, clinical research. Further, HAIRGENESIS® is the only naturally-based hair loss treatment product line with its positive results proven and published in the peer-reviewed medical literature; i.e. pubmed.com. Why is this important? It is important because critical peer review constitutes the gold standard of scientific validation in the medical community.
When a drug or product has been critically peer reviewed and accepted for publication on pubmed.com it has risen to the same standard applied to the medicines you take and allow to be taken by your family. The task of achieving the aforementioned is daunting to say the least. But HAIRGENESIS® can point to multiple critically peer-reviewed scientific monographs published on pubmed.com, including several undertaken in world class universities, including the University of Chicago, SUNY, and the University of Albany, Center for Functional Genomics.
Of late, some products in the hair loss treatment category have gotten wise to the idea that consumers desire actual scientific credentials but instead of undertaking the protracted, difficult and onerous process associated with publication on pubmed they have skirted the process by selecting for ‘pay to play’ journals, in other words, journals that have very little credibility in the scientific and medical community. Such ‘research’ will tend not to be found on pubmed because it does not rise to the level of scientifically valid work.
Here is a link to an excellent article that describes this less-than-ethical phenomenon: http://science.sciencemag.org/content/342/6154/60
As a consumer, one must become a bit educated because you are trusting the health of your hair to a product line which purports to offer safety and efficacy. So you ought to ask yourself, would you take an antibiotic that had not undergone the sort of painstaking scrutiny which characterizes research found on pubmed.com? Of course you wouldn’t! So why should you trust the health of your hair to a product which had not risen to the same first tier level? Choose wisely. Choose HAIRGENESIS®.